Mehta, P., and V. Chandran. “IL-17 Inhibition Vs IL-23 Inhibition for Psoriatic Arthritis: An Ongoing Debate”. Canadian Rheumatology Today, vol. 2, no. 2, Aug. 2025, pp. 4–14, doi:10.58931/crt.2025.2262.